Free Trial

Alpha Cognition (ACOG) Competitors

Alpha Cognition logo
$9.97 +0.01 (+0.10%)
As of 04:00 PM Eastern

ACOG vs. IOVA, URGN, TLRY, TNGX, STOK, PRME, DNTH, PHAT, UPB, and XNCR

Should you be buying Alpha Cognition stock or one of its competitors? The main competitors of Alpha Cognition include Iovance Biotherapeutics (IOVA), Urogen Pharma (URGN), Tilray Brands (TLRY), Tango Therapeutics (TNGX), Stoke Therapeutics (STOK), Prime Medicine (PRME), Dianthus Therapeutics (DNTH), Phathom Pharmaceuticals (PHAT), Upstream Bio (UPB), and Xencor (XNCR). These companies are all part of the "pharmaceutical products" industry.

Alpha Cognition vs. Its Competitors

Alpha Cognition (NASDAQ:ACOG) and Iovance Biotherapeutics (NASDAQ:IOVA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk.

Alpha Cognition has higher earnings, but lower revenue than Iovance Biotherapeutics. Alpha Cognition is trading at a lower price-to-earnings ratio than Iovance Biotherapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha CognitionN/AN/A-$14.64M-$1.20-8.31
Iovance Biotherapeutics$212.68M4.91-$372.18M-$1.24-2.52

Alpha Cognition has a beta of 2.73, meaning that its share price is 173% more volatile than the S&P 500. Comparatively, Iovance Biotherapeutics has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500.

Alpha Cognition presently has a consensus price target of $20.00, indicating a potential upside of 100.60%. Iovance Biotherapeutics has a consensus price target of $12.22, indicating a potential upside of 290.49%. Given Iovance Biotherapeutics' higher possible upside, analysts plainly believe Iovance Biotherapeutics is more favorable than Alpha Cognition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Cognition
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Iovance Biotherapeutics
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.33

Alpha Cognition has a net margin of 0.00% compared to Iovance Biotherapeutics' net margin of -176.49%. Iovance Biotherapeutics' return on equity of -49.71% beat Alpha Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha CognitionN/A -65.83% -48.21%
Iovance Biotherapeutics -176.49%-49.71%-39.18%

77.0% of Iovance Biotherapeutics shares are held by institutional investors. 14.0% of Alpha Cognition shares are held by company insiders. Comparatively, 10.3% of Iovance Biotherapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Iovance Biotherapeutics had 18 more articles in the media than Alpha Cognition. MarketBeat recorded 19 mentions for Iovance Biotherapeutics and 1 mentions for Alpha Cognition. Alpha Cognition's average media sentiment score of 1.87 beat Iovance Biotherapeutics' score of 0.14 indicating that Alpha Cognition is being referred to more favorably in the media.

Company Overall Sentiment
Alpha Cognition Very Positive
Iovance Biotherapeutics Neutral

Summary

Iovance Biotherapeutics beats Alpha Cognition on 8 of the 15 factors compared between the two stocks.

Get Alpha Cognition News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACOG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACOG vs. The Competition

MetricAlpha CognitionMED IndustryMedical SectorNASDAQ Exchange
Market Cap$159.72M$3.04B$5.74B$9.51B
Dividend YieldN/A2.40%4.60%3.99%
P/E Ratio-8.3121.2028.0820.03
Price / SalesN/A338.37460.87103.88
Price / CashN/A43.2336.5559.01
Price / Book3.858.338.645.90
Net Income-$14.64M-$55.19M$3.24B$258.66M
7 Day Performance-0.20%5.85%4.11%2.20%
1 Month Performance4.18%17.58%10.74%12.75%
1 Year PerformanceN/A5.05%34.43%19.27%

Alpha Cognition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACOG
Alpha Cognition
1.7311 of 5 stars
$9.97
+0.1%
$20.00
+100.6%
N/A$159.72MN/A-8.31N/APositive News
IOVA
Iovance Biotherapeutics
4.6168 of 5 stars
$2.01
+7.5%
$12.22
+508.1%
-64.0%$671.20M$164.07M-1.62500Analyst Forecast
Options Volume
Gap Up
High Trading Volume
URGN
Urogen Pharma
4.5082 of 5 stars
$14.49
+1.8%
$32.86
+126.8%
+10.0%$668.13M$90.40M-4.56200
TLRY
Tilray Brands
1.8105 of 5 stars
$0.66
+13.1%
$1.92
+191.8%
-60.7%$661.07M$788.94M-0.632,650Upcoming Earnings
Options Volume
TNGX
Tango Therapeutics
1.6669 of 5 stars
$6.09
+2.7%
$12.20
+100.3%
-31.9%$660.12M$40.99M-4.9990Positive News
STOK
Stoke Therapeutics
4.2492 of 5 stars
$12.06
+1.7%
$24.75
+105.2%
-5.4%$658.48M$36.56M15.27100
PRME
Prime Medicine
3.853 of 5 stars
$4.80
+10.3%
$10.08
+110.1%
-20.8%$645.57M$3.85M-2.34234Gap Down
High Trading Volume
DNTH
Dianthus Therapeutics
1.3859 of 5 stars
$20.03
-0.1%
$53.00
+164.6%
-21.7%$644.17M$6.24M-6.9580Positive News
PHAT
Phathom Pharmaceuticals
4.31 of 5 stars
$9.06
-1.3%
$17.50
+93.2%
-21.0%$632.48M$55.25M-1.73110Positive News
UPB
Upstream Bio
1.7838 of 5 stars
$11.73
+2.2%
$56.50
+381.7%
N/A$631.00M$2.30M0.0038News Coverage
XNCR
Xencor
4.5069 of 5 stars
$8.85
+0.2%
$28.00
+216.4%
-54.7%$629.85M$110.49M-2.89280Positive News

Related Companies and Tools


This page (NASDAQ:ACOG) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners